Spiral ganglion neurons (SGNs), the primary afferent neurons of the cochlea, degenerate following a sensorineural hearing loss (SNHL) due to lack of trophic support normally received from hair cells. Cell transplantation is emerging as a potential strategy for inner ear rehabilitation, as injected cells may be able to replace damaged SGNs in the deafened cochlea. An increase in the number of surviving SGNs may result in improved efficacy of cochlear implants (CIs). We examined the survival of partially differentiated mouse embryonic stem cells (MESCs), following xenograft transplantation into the deafened guinea pig cochlea (n = 15). Cells were delivered directly into the left scala tympani via microinjection through the round window. Small numbers of MESCs were detected in the scala tympani for up to 4 weeks following transplantation and a proportion of these cells retained expression of neurofilament protein 68 kDa in vivo. While this delivery method requires refinement for effective long-term replacement of damaged SGNs, small numbers of MESCs were capable of survival in the deafened mammalian cochlea for up to 4 weeks, without causing an inflammatory tissue response.
INTRODUCTION
of CIs is due, at least in part, to the survival of a critical number of SGNs. Greater numbers of SGNs is likely to result in improved clinical outcomes for CI subjects In mammals, damage to sensory receptor cells (hair cells) of the inner ear results in a permanent sensorineu- (6, 20) . Previous studies have reported that SGNs can be protected from degeneration following a SNHL by the ral hearing loss (SNHL). Inner hair cells normally provide trophic support to spiral ganglion neurons (SGNs), exogenous supply of neurotrophins (5, 7, 15, 18, 19, 34, 39) . While significant SGN survival is observed during the the primary afferent neurons of the auditory nerve, in the form of neurotrophins (38) . Loss of these inner hair delivery of neurotrophins, this survival effect is lost immediately following the cessation of treatment (7) . An cells initiates a number of morphological and physiological changes that ultimately result in the degeneration of effective therapy for hearing loss may therefore employ techniques capable of replacing degenerating SGNs. In SGNs. An initial rapid loss of peripheral processes (36) is followed by a more gradual degeneration of cell bod-order to provide beneficial rehabilitation, such an approach would need to include delivery of replacement ies within Rosenthal's canal (16, 32, 33) . Degeneration of auditory neurons is an ongoing process that eventually cells to the target site, Rosenthal's canal (Fig. 1 ). Cellbased therapy offers such alternatives. results in very small numbers of surviving SGNs in long-term deafened animals (8, 16) . This process and re-Recent studies investigating the viability of cellbased therapy in the cochlea are summarized in Table 1 . lated terminology is illustrated in Figure 1 .
Currently, the only clinical treatment for a severe-While these studies utilize different cell types and methods for transplantation, they can be grouped into three profound SNHL is a cochlear implant (CI), a neural prosthesis capable of directly stimulating residual SGNs categories based on the primary aim of the research: 1) to regenerate hair cells thereby restoring auditory func-following the loss of hair cells (30) . The clinical success Figure 1 . Anatomy of the deafened guinea pig cochlea and schematic of scala tympani cell delivery technique. Transverse section of a guinea pig cochlea 4 weeks following ototoxic deafening, labeled with H&E (left). The auditory nerve (AN) is located in the middle of the structure and comprises central processes, which originate from spiral ganglion neurons (SGNs) in Rosenthal's canal (RC; refer to inset). The AN and RC are collectively referred to as the modiolus. Encircling the modiolus are four cochlear turns, each comprising three fluid-filled compartments: scala vestibuli (SV), scala media (SM), and scala tympani (ST). The ST and SV are joined at the apex and are filled with the same fluid, perilymph. The SM is filled with endolymph, and is isolated from the ST and SV. MESCs were transplanted into the ST, at the base of the cochlea, as illustrated. Scale bar: 300 µm. Inset: Higher magnification photomicrograph illustrating more comprehensively the anatomy of a single cochlear turn. The SV and SM are separated by Reissner's membrane while the basilar membrane separates the SM and ST. Note the lack of hair cells in deafened animals (arrow), which are normally present at this location on the basilar membrane. SGNs are located within RC (circled) and are degenerating. Peripheral processes extend from SGNs toward the normal site of hair cells (arrow). RC and the ST are separated by a thin bony wall called the osseous spiral lamina (arrowheads). This wall contains numerous bony pores or canaliculae perforantes, which are thought to provide fluid communication channels between the SGNs housed within RC and the ST. Scale bar: 100 µm. tion; 2) to provide neurotrophic support to degenerating and embryonic stem cells (10) into the auditory system have been reported. Some of these studies were con-SGNs; and 3) to replace degenerating SGN populations in an attempt to increase the efficacy of CIs. The present ducted with a view to replacing damaged SGNs in the deafened mammalian cochlea (11, 21, 23, 24) . Of these study explores the last of these goals using a clinically relevant mammalian model of deafness and mouse em-studies, Hu et al. (11) and Olivius et al. (23, 24) delivered whole explants of DRGNs into the base of the co-bryonic stem cells (MESCs).
The ability of stem cells to divide and differentiate chlea via the scala tympani. Others have examined cell transplantation directly into the auditory nerve (21,27). into specialized cell types makes them ideal candidates for cell replacement therapy and tissue repair (25) . Em-In all cases, the authors report survival and migration of transplanted cells within the cochlea for periods of up to bryonic stem cells hold significant potential for regenerative medicine, due primarily to their capacity to differ-4 weeks. A recent paper by Hu et al. (10) reported survival and differentiation of MESCs delivered to the co-entiate into numerous cell and tissue types. In this way embryonic stem cells could be induced to differentiate chlea within a DRGN explant. However, there are presently no published studies describing direct delivery of into SGNs, which may provide a source of replacement cells to the degenerating auditory nerve and ultimately embryonic stem cell suspensions into the deafened mammalian cochlea, to address the replacement of SGNs and improve CI function. Previous attempts to transplant adult stem cells (12, 14, 21, 35) , dorsal root ganglion neu-improvement of CI function. A variety of methodologies have been utilized to de-rons (DRGNs) (11,23,24), and a combination of DRGNs liver cells to the cochlea (Table 1) . These include injec-for the current study (Table 2) . Guinea pigs were systemically deafened, allowed to recover for 2 weeks, and tion into semicircular canals, adjacent to the cochlea (12), direct transplantation into the cochlea (14,35), de-then transplanted with either 9-day differentiated MESCs (n = 15) or Dulbecco's modified Eagle medium (DMEM; livery into the scala media (9) or scala tympani (10-12, 23, 24) , and direct injection into the auditory nerve Invitrogen, Victoria, Australia) (n = 5). Animals were sacrificed at 1-, 2-, or 4-week time points (Table 2) . All (21,27). We chose a scala tympani approach for cell transplantation, which enabled the delivery of MESCs animal handling and technical procedures were conducted in accordance with the guidelines set by the directly into the cochlea, proximal to the target site. This clinically relevant technique minimized mechanical Royal Victorian Eye and Ear Hospital Animal Research and Ethics Committee (approval numbers 02/083 and damage to the cochlea. Aspects of this work have appeared in abstract form (2,3). 02/090).
MATERIALS AND METHODS

Deafening Procedure Experimental Groups
The hearing status of all guinea pigs was evaluated using standard click-evoked auditory brainstem responses Twenty pigmented adult guinea pigs (400-600 g) were taken from a mixed gender and gene pool and used (ABRs) (8). Normal hearing guinea pigs were bilaterally Indianapolis, IN, USA), and 10 ng/ml basic fibroblast growth factor (bFGF; Roche). NM was changed again at day 8 and EBs prepared for surgery after 9 days in vitro, as detailed in Figure 2 . The stem cell differentiadeafened by coadministration of the ototoxic aminoglytion protocol was timed so that cells would be ready for coside kanamycin monophosphate (Sigma, St. Louis, MO, transplantation exactly 14 days postdeafening ( Fig. 2) . USA) and the loop diuretic frusemide (Troy Labora-Preparation for Surgery. EBs were collected after 9 tories, Sydney, Australia). Briefly, guinea pigs were andays of differentiation in vitro and washed twice in unesthetized using ketamine (60 mg/ml, Parnell Laborasupplemented DMEM. EBs were then resuspended in 1 tories, Sydney, Australia) and xylazil (4 mg/ml; Troy ml DMEM, transferred to a sterile Eppendorf TM tube and Laboratories), and 2% lignocaine (Troy Laboratories) gently dissociated using a 25-gauge needle. The resultadministered subcutaneously to the incision site. The ing single-cell suspension was centrifuged for 10 s at right jugular vein was exposed and cannulated using 1000 rpm, the supernatant discarded, and the cells resussterile surgical techniques and then slowly infused with pended in unsupplemented DMEM to give a final cell frusemide (110 mg/kg), tied-off with silk, and the wound concentration of ϳ1 × 10 6 viable cells/ml. sealed with cyanoacrylate. Kanamycin monophosphate (440 mg/kg) was administered subcutaneously immedi-Agar Embedding and Processing of MESCs In Vitro. ately postsurgery. The deafening technique described A further 100 µl of 9-day differentiated EBs was transmimics the clinical scenario by selectively damaging ferred into a sterile Eppendorf TM tube, excess media rehair cells, subsequently causing a SNHL and gradual demoved, and cells washed twice in 1 ml of sterile PBS. generation of SGNs ( Fig. 1 ). All animals used in this After each wash, EBs were allowed to settle on the botstudy were confirmed profoundly deaf via ABRs, 2 weeks tom of the tube and any excess PBS removed carefully postdeafening (click-evoked ABR thresholds ≥ 98 dB without disturbing the pellet. EBs were then fixed for 30 peak equivalent sound pressure level) (8).
min in 4% paraformaldehyde (PFA; BDH Laboratories, Leicestershire, UK) and rinsed three times in sterile MESCs PBS, as described previously. EBs were transferred quickly to preheated liquid agar (4%). After cooling and Maintenance of MESCs. MESCs {R1 B5-EGFP hardening at room temperature, agar blocks were em-[Tg(GFPU)5 Nagy/J]} were obtained from Dr. A. Nagy bedded in paraffin wax and sectioned at 5 µm. These (Mt Sinai Hospital, Toronto) and utilized in this study. sections were used for immunohistochemical compari-These cells were genetically modified to express green son with in vivo sections. fluorescent protein (GFP) so that they could be detected in vivo using direct fluorescent microscopy. Undifferen-Transplantation Surgery tiated MESCs were grown in standard embryonic stem cell media (ESCM) comprising DMEM supplemented Two weeks postdeafening, guinea pigs were anesthetized as previously described and the round window of with 10% fetal bovine serum (FBS; Invitrogen), 1% penicillin/streptomycin (Invitrogen), 1% nucleosides (Sigma), the left cochlea exposed via a dorsal approach using sterile surgical techniques. MESCs were prepared for 1% nonessential amino acids (Invitrogen), 1% L-glutamine (Sigma), 1 ml/L 1000× β-mercaptoethanol (BME; transplantation concomitant to exposure of the round window. The round window was perforated using a 30-GIBCO/BRL, Melbourne, Australia), and 1 ml/L (1000 units) leukemia inhibitory factor (LIF; Chemicon, Teme-gauge needle and a small volume of perilymph was aspirated. MESCs or DMEM (control) was delivered through cula, CA, USA). MESCs were passaged every 2-3 days Timeline of differentiation and transplantation methodology for MESCs. Twenty guinea pigs were systemically deafened and allowed to recuperate for 2 weeks. Four days after the deafening surgery, undifferentiated MESCs underwent a 9-day induction protocol to sequentially generate embryoid bodies (EBs) and neurectoderm (early neuronal tissue), as described in Materials and Methods. Two weeks postdeafening, 15 guinea pigs received a 2 µl suspension of MESCs, delivered into the left cochlea (see Fig.  1 ). An additional five animals received a transplant of DMEM alone into the left cochlea. The right cochleae of all animals served as a deafened, untreated control. Animals receiving a transplant of MESCs (n = 15) were placed randomly into three groups (five animals per group) and perfused 1, 2, or 4 weeks post-stem cell transplantation (group 1, 2, or 3, respectively). Animals receiving a transplant of DMEM (n = 5) were perfused 2 weeks postdelivery. the round window into the scala tympani of the left co-or 4 (n = 5) weeks posttransplantation. Control animals that received DMEM were euthanized in the same way, chlea (Fig. 1 ) via a sterile polyurethane and polyimide cannula attached to a 10-µl Hamilton syringe (Coherent 2 weeks following surgery. The left and right cochleae were removed and postfixed for a further 24 h and then Scientific, Hilton, Australia). The syringe was operated by an electronic microdelivery pump (UltraMicroPump decalcified in 10% ethylenediamine tetraacetic acid (EDTA; Applichem, Darmstadt, Germany) in PBS for II, World Precision Instruments, FL, USA), which allowed for the consistent delivery of cells and media into approximately 2 weeks. Decalcification was confirmed via radiography and the cochleae trimmed and orientated the cochlea. A total volume of 2 µl (half the volume of the guinea pig scala tympani) (37) was delivered at a in 4% agar. Specimens were embedded in paraffin wax, sectioned at 5 µm in the midmodiolar plane, and placed rate of 0.5 µl/min. This technique was developed in our laboratory by Andrew in 2003 (1). Following transplan-onto superfrost slides (Menzel-Glaser, Braunschweig, Germany). tation the perforated round window was sealed with muscle and the wound sutured in two layers. The patency of the delivery system was tested before and after Detection of MESCs. All sections were dewaxed in Histoclear and rehydrated using descending concentra-cell transplantation by delivering 0.5 µl of cell suspension at a rate of 0.5 µl/min into a sterile dish. These tions of alcohol. To examine cochlear morphology, representative slides were stained using hematoxylin and samples were then used to estimate the number and viability of cells delivered into the cochlea (ϳ2000 viable eosin (H&E). Cell identification and survival was indicated by direct fluorescent microscopy for endogenous cells per cochlea).
GFP in combination with the nuclear marker 4′-6-diami-Histology and Immunohistochemistry dino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA). In addition, a selection of slides were la-Guinea pigs that received MESC transplants were euthanized via intraperitoneal injection of sodium pento-beled for neuronal marker neurofilament 68 kDa (NF-L; Chemicon), using standard antigen retrieval and immu-barbitone (160 mg/kg; Troy Laboratories) and transcardially perfused with 4% PFA at 1 (n = 5), 2 (n = 5), nohistochemical techniques. Briefly, sections were heated to 100°C in 1 mM EDTA, pH 8.0, allowed to cool to Identification of Endogenous GFP in MESCs In Vitro room temperature, then submerged into H 2 O 2 for 30 min
To confirm endogenous GFP expression in vitro, 9to block endogenous peroxidase activity. After permeaday differentiated MESCs were labeled with the nuclear bilization in 0.1% Triton-X (Sigma) tissues were incumarker DAPI and examined using direct fluorescent mibated in rabbit anti-NF-L (1:400) overnight, thoroughly croscopy (Fig. 4) . MESCs were identified by expression rinsed in blocking solution, then incubated sequentially of the nuclear marker DAPI (Fig. 4A ) and endogenous in biotinylated goat anti-rabbit (1:200; Vector Labora-GFP (Fig. 4B ). Overlay shows colocalization of DAPI tories) and avidin-biotin complex (1:100; Vector Laboand GFP (Fig. 4C ). ratories). Sections were rinsed in PBS and diaminoben-
Identification of GFP-Positive MESCs in the Deafened zadine tetrahydrochloride (DAB; Vector Laboratories)
Guinea Pig Cochlea applied until a color change was observed. DAB-labeled sections were dehydrated in 100% alcohol and Histo-To confirm cell identification, transplanted MESCs clear, then mounted in DPX (ProSciTech, Queensland, were visualized via direct fluorescent microscopy for en-Australia).
dogenous GFP and DAPI (Fig. 5 ). Small numbers of All sections were evaluated under a Zeiss Axioplan MESCs were identified in the scala tympani of left Microscope (Zeiss, Victoria, Australia) using both trans-(MESC-treated) cochleae, both in the basal turns (arrowmitted light and a fluorescent lamp with appropriate filheads) and in more apical turns. When quantified, there ters (Zeiss filter set 00; 488000-0000, Zeiss filter set 02; was a significant decline (p = 0.01) in the number of 488002-0000, and Zeiss filter set 13; 488013-0000).
transplanted MESCs in the left scala tympani (lower Photomicrographs were taken using a Zeiss, AxioCam basal turn) between 2 and 4 weeks in vivo ( Fig. 6 ). 12V monochrome digital camera.
There were no MESCs detected in the scala tympani of DMEM-treated cochleae (Fig. 3B ).
Quantification of MESCs In Vivo. The presence of MESCs in the deafened cochlea was examined qualita-
Detection of Transplanted MESCs Within the Target tively in the scala tympani of all turns. In order to quan-Site, Rosenthal's Canal tify the number of surviving MESCs in the cochlea, we Using direct fluorescent microscopy for endogenous randomly selected nine sections between the injection GFP and DAPI, we detected MESCs within the target site (round window) and the midmodiolar plane from site, Rosenthal's canal, in the left cochleae ( Fig. 7) . left (MESC-treated) cochleae. All sections were labeled When quantified using the described methodology, there with DAPI and visualized using direct fluorescent miwas no significant difference observed between the croscopy (previously described). Surviving MESCs were number of stem cells detected within Rosenthal's canal identified by size (between 5 and 15 µm in diameter) at any time point ( Fig. 8) . At all three time points, the and by coexpression of endogenous GFP and the nuclear mean number of stem cells observed within Rosenthal's DAPI. In each section we counted the number of MESCs canal was less than one cell per section. in the lower basal turn scala tympani, and within Rosenthal's canal. A two-way analysis of variance was used Neurofilament Labeling of MESCs In Vitro and In Vivo to detect whether there was a significant difference be-Using immunohistochemical techniques and light mitween the number of surviving cells in the left cochleae croscopy, 9-day differentiated EBs and representative at each time point. All statistical analyses were percochlear sections were labeled for neuron-specific proformed using Sigma Stat 3 software.
tein NF-L. A range of NF-L expression was observed in neurectodermal EBs in vitro, with the strongest labeling RESULTS occurring on the periphery of the embryoid body, where Detection of MESCs in the Deafened Guinea the most differentiated cells are located (Fig. 9A ). NF-Pig Cochlea L expression was retained in a portion of transplanted H&E staining was employed to detect the presence MESCs for up to 4 weeks in vivo (Fig. 9B ). There were of transplanted cells in the scala tympani of MESCno NF-L-positive cells observed in the scala tympani of treated and DMEM-treated cochleae, for periods up to 4 control sections from DMEM-treated cochleae (Fig. 9C ). weeks posttransplantation (Fig. 3) . Transplanted cells DISCUSSION were identified in the scala tympani of MESC-treated cochleae (Fig. 3A) , but not in DMEM-treated (control)
Previous studies transplanting live cells into the mammalian auditory system have been published (9-cochleae ( Fig. 3B) . Interestingly, there was no inflammatory tissue response detected in any cochleae treated 14,21, 23, 24, 27, 35) . Although cell type and transplantation methodology varied between laboratories, all report with MESCs (n = 15) or DMEM (n = 5), at any of the time points examined (Fig. 3A and B, respectively) .
survival of transplanted cells for 3-9 weeks following delivery. Based on previous research using guinea pig toarchitechture and free floating within the perilymph. While previous studies have reported the survival of ex-animal models, we decided to deliver cells directly into the scala tympani. We anticipated that the chosen ap-ogenous cells in the mammalian cochlea for short periods (9-14,21, 23, 24, 27, 35) , few studies have quantified proach would enable the efficient delivery of cells proximal to the principle target site (SGNs within Rosenthal's the number of surviving cells. Where counts have been performed, there appears to be a decrease in the number canal), while minimizing mechanical trauma to the cochlear cytoarchitecture. Furthermore, we considered this of surviving cells after 4 weeks in vivo. According to Iguchi and colleagues, approximately 10% of neural technique the most relevant from a clinical and surgical perspective.
stem cells delivered to the mouse cochlea were detected 4 weeks following transplantation (13). Similar findings Survival and Dispersal of MESCs have been reported more recently in guinea pigs (10,12). in the Mammalian Cochlea Specifically, these studies report a decline in the number stem cells transplanted into the guinea pig scala tympani The primary indicators of the efficacy of our approach were the survival and dispersal of MESCs in the between 2 and 4 weeks. Quantitative data from the current study also shows a significant decline in the number deafened guinea pig cochlea. Examination of cochlear sections revealed that transplanted MESCs could be de-of cells in the scala tympani between 2 and 4 weeks in vivo (Fig. 6 ). The reason for this decline in surviving tected in small numbers for up to 4 weeks in vivo, and were capable of widespread dispersal throughout the co-cells after 4 weeks in vivo is unclear; however, we suggest that this may be related to both the delivery site chlea. Surviving cells were observed attached to the cy- and to the presence of a cochlear aqueduct-a canal that dispersal, at least through the perilymphatic space, is via the movement of perilymph, which flows at a slow rate connects the fluid-filled inner ear to the cerebrospinal fluid (CSF) of the CNS. of 1.6 nl/min in an apical direction (22) . While the flow of perilymph may provide an innate dispersal mecha-While some authors have suggested that transplanted cells migrate within the cochlea, it seems more likely nism for transplanted cells, it has the potential disadvantage of transporting the cells to regions distal to their that the primary mechanism behind intracochlear cell target site. Given that guinea pigs have a patent cochlear aqueduct, it is feasible that a large proportion of cells in suspension could disperse from the cochlea into the CSF via this route. This may explain the observed decrease in the number of transplanted cells between 2 and 4 weeks in vivo, both in this study and previous studies (10,12). Notably, in previous studies delivering live cells into the scala tympani, there has been no attempt to confirm whether transplanted cells could be detected in the cochlear aqueduct or CSF. Examination of these compartments in future studies will be necessary in order to confirm this hypothesis.
Detection of Transplanted MESCs Within Rosenthal's Canal
A small number of MESCs were detected in Rosenthal's canal and observed within close proximity to surviving SGNs. Similar findings have been reported by other groups, following cell transplantation in guinea pigs (23) and rats (11). We hypothesize that transplanted cells are able to reach these otherwise confined areas via pores that are present in the osseous spiral lamina, lining the medial wall of the scala tympani (Fig. 1) . These pores, or canaliculae perforantes, are reported to provide fluid communication channels between Rosenthal's canal and the perilymphatic fluid in the scala tympani (4,17, 28, 29) . Previous research has demonstrated that canaliculae perforantes are present in guinea pigs (4,28), and encouragingly, in humans where they are reported to be both numerous and large (31) . While transplanted cells were detected within Rosenthal's canal in the present study, they did not occur in significant numbers to be considered an efficient means by which to replace degenerating SGNs in the deafened cochlea (Fig. 8 ). This finding implies the necessity for a more directed delivery technique.
Future Directions and Clinical Implications for Cell-Based Therapy in the Mammalian Cochlea
Results from the present study suggest that the delivery of cell suspensions to the cochlea via the scala this approach is surgically difficult and causes mechani-10 µm.
cal damage to the modiolus, it has been used successfully by other groups (21, 27) .
It is interesting to note that a portion of transplanted 
